The levels of Lp(a) in human plasma are genetically modulated, and Precocious Coronary Artery Disease (PROCARDIS) study showed that two Lp(a) single nucleotide polymorphisms (SNPs) accounted for 36% of variation in Lp(a) levels3. Here, LPA is linked to coronary artery disorder.